Genscript Biotech Co. (OTCMKTS:GNNSF) Short Interest Update

Genscript Biotech Co. (OTCMKTS:GNNSF) saw a significant decline in short interest in the month of February. As of February 15th, there was short interest totalling 549,600 shares, a decline of 70.6% from the January 31st total of 1,867,800 shares. Based on an average daily volume of 200 shares, the days-to-cover ratio is currently 2,748.0 days.

Genscript Biotech Stock Performance

OTCMKTS:GNNSF remained flat at C$1.90 on Friday. Genscript Biotech has a 1-year low of C$1.05 and a 1-year high of C$2.05. The stock’s fifty day moving average price is C$1.39 and its two-hundred day moving average price is C$1.41.

Genscript Biotech Company Profile

Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, the People's Republic of China, Japan, the other Asia Pacific regions, and internationally. The company operates through four segments: Life Science Services and Products; Biologics Development Services; Industrial Synthetic Biology Products; and Cell Therapy.